Annual Retained Earnings
-$371.26 M
-$101.74 M-37.75%
31 December 2023
Summary:
Tango Therapeutics annual retained earnings is currently -$371.26 million, with the most recent change of -$101.74 million (-37.75%) on 31 December 2023. During the last 3 years, it has fallen by -$268.15 million (-260.09%). TNGX annual retained earnings is now -260.09% below its all-time high of -$103.10 million, reached on 31 December 2020.TNGX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$463.89 M
-$29.17 M-6.71%
30 September 2024
Summary:
Tango Therapeutics quarterly retained earnings is currently -$463.89 million, with the most recent change of -$29.17 million (-6.71%) on 30 September 2024. Over the past year, it has dropped by -$123.39 million (-36.24%). TNGX quarterly retained earnings is now -349.94% below its all-time high of -$103.10 million, reached on 31 December 2020.TNGX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TNGX Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -37.8% | -36.2% |
| 3 y3 years | -260.1% | -233.0% |
| 5 y5 years | - | - |
TNGX Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -260.1% | at low | -233.0% | at low |
| 5 y | 5 years | -260.1% | at low | -349.9% | at low |
| alltime | all time | -260.1% | at low | -349.9% | at low |
Tango Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$463.89 M(+6.7%) |
| June 2024 | - | -$434.72 M(+6.2%) |
| Mar 2024 | - | -$409.17 M(+10.2%) |
| Dec 2023 | -$371.26 M(+37.8%) | -$371.26 M(+9.0%) |
| Sept 2023 | - | -$340.49 M(+7.0%) |
| June 2023 | - | -$318.23 M(+7.0%) |
| Mar 2023 | - | -$297.52 M(+10.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | -$269.51 M(+67.1%) | -$269.51 M(+12.1%) |
| Sept 2022 | - | -$240.45 M(+13.7%) |
| June 2022 | - | -$211.40 M(+13.3%) |
| Mar 2022 | - | -$186.54 M(+15.6%) |
| Dec 2021 | -$161.34 M(+56.5%) | -$161.34 M(+15.8%) |
| Sept 2021 | - | -$139.29 M(+35.1%) |
| Dec 2020 | -$103.10 M | -$103.10 M |
FAQ
- What is Tango Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Tango Therapeutics?
- What is Tango Therapeutics annual retained earnings year-on-year change?
- What is Tango Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Tango Therapeutics?
- What is Tango Therapeutics quarterly retained earnings year-on-year change?
What is Tango Therapeutics annual retained earnings?
The current annual retained earnings of TNGX is -$371.26 M
What is the all time high annual retained earnings for Tango Therapeutics?
Tango Therapeutics all-time high annual retained earnings is -$103.10 M
What is Tango Therapeutics annual retained earnings year-on-year change?
Over the past year, TNGX annual retained earnings has changed by -$101.74 M (-37.75%)
What is Tango Therapeutics quarterly retained earnings?
The current quarterly retained earnings of TNGX is -$463.89 M
What is the all time high quarterly retained earnings for Tango Therapeutics?
Tango Therapeutics all-time high quarterly retained earnings is -$103.10 M
What is Tango Therapeutics quarterly retained earnings year-on-year change?
Over the past year, TNGX quarterly retained earnings has changed by -$123.39 M (-36.24%)